Kureha Resets Growth Roadmap With New 2035 Strategy and 2028 Mid-Term Targets

Kureha ( (JP:4023) ) has shared an announcement.

Kureha has unveiled a new long-term management plan through fiscal 2035 and a mid-term plan covering fiscal 2026 to 2028, while scrapping its previous 2030 targets after reassessing its reliance on profit growth from the PVDF business. The group will reorganize around three core segments—Advanced Materials, Specialty Chemicals, and Life Science—reflecting a strategy to diversify earnings and build a portfolio that better balances growth and risk.

Under the new framework, Kureha targets core operating profit of 19 billion yen and EBITDA of 33 billion yen by fiscal 2028, alongside a ROIC of 4.8%, ROE of 8%, and an equity ratio of about 50%. By fiscal 2035, the company aims to become a high-value-added, technology-led enterprise capable of consistently converting its proprietary technologies into profits, with long-term goals of achieving 8% ROIC and 12% ROE to enhance returns for stakeholders.

The most recent analyst rating on (JP:4023) stock is a Hold with a Yen3800.00 price target. To see the full list of analyst forecasts on Kureha stock, see the JP:4023 Stock Forecast page.

More about Kureha

Kureha Corporation is a Japanese chemicals manufacturer focused on advanced materials, specialty chemicals, and life science products. The company positions itself as a technology-driven player, aiming to leverage proprietary technologies to deliver high value-added offerings and strengthen its competitiveness in global markets.

Average Trading Volume: 396,007

Technical Sentiment Signal: Buy

Current Market Cap: Yen141B

See more insights into 4023 stock on TipRanks’ Stock Analysis page.